Predominant Mycobacterium tuberculosis families and high rates of recent transmission among new cases are not associated with primary multidrug resistance in Lima, Peru

Journal of Clinical Microbiology

Volumn 53, Issue 6, 2015, Pages 1854-1863

  Barletta, Francesca ^a   Otero, Larissa ^a   De Jong, Bouke C ^b,c,d   Iwamoto, Tomotada ^e   Arikawa, Kentaro ^e   Van Der Stuyft, Patrick ^d,f   Niemann, Stefan ^g,h   Merker, Matthias ^g,h   Uwizeye, Cécile ^d   Seas, Carlos ^a   Rigouts, Leen ^d,i  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b MRC Unit   (Gambia)

^c NEW YORK UNIVERSITY   (United States)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e KOBE INSTITUTE OF HEALTH   (Japan)

^f GHENT UNIVERSITY   (Belgium)

^g RESEARCH CENTER BORSTEL   (Germany)

^h Partner Site Borstel   (Germany)

ⁱ UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM EXAMINATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIAL INTERSPERSED REPETITIVE UNIT TYPING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERU; POPULATION STRUCTURE; PRIORITY JOURNAL; SPOLIGOTYPING; VARIABLE NUMBER OF TANDEM REPEAT; DRUG EFFECTS; GENETICS; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; PROSPECTIVE STUDY; SPUTUM; TRANSMISSION; TUBERCULOSIS; YOUNG ADULT;

MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PERU; PROSPECTIVE STUDIES; SPUTUM; TUBERCULOSIS; YOUNG ADULT;

EID: 84929378817     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03585-14     Document Type: Article

References (66)

1. Mathers CD, Boerma T, Ma Fat D. 2009. Global and regional causes of death. Br Med Bull 92:7-32. http://dx.doi.org/10.1093/bmb/ldp028.
2. World Health Organization. 2014. Global tuberculosis report. WHO/HTM/TB/2014.08. World Health Organization, Geneva, Switzerland.
3. Bonilla CA, Crossa A, Jave HO, Mitnick CD, Jamanca RB, Herrera C, Asencios L, Mendoza A, Bayona J, Zignol M, Jaramillo E. 2008. Management of extensively drug-resistant tuberculosis in Peru: cure is possible. PLoS One 3: e2957. http://dx.doi.org/10.1371/journal.pone.0002957.
4. Ministerio de Salud. 2013. Informe operacional MINSA: otras instituciones. 2013/AMHE/JECC. Ministerio de Salud, Lima, Peru.
5. Instituto Nacional de Estadística e Informática. 2012. Estimaciones y proyecciones de población por sexo, según departamento, provincia y distrito, 2000 -2015. Instituto Nacional de Estadística e Informática, Lima, Peru.
6. Ministerio de Salud. 2011. Análisis de la situación de salud 2011 de la Dirección de Salud IV Lima Este. Ministerio de Salud, Lima, Peru.
7. Ministerio de Salud. 2010. Dirección de Salud IV Lima Este plan operativo institucional ejercicio fiscal 2010. Ministerio de Salud, Lima, Peru.
8. World Health Organization. 2013. Global tuberculosis report. WHO/HTM/TB/2013.11. World Health Organization, Geneva, Switzerland.
9. Ministerio de Salud. 2010. Estrategia sanitaria nacional para la prevención y control de la tuberculosis: informe operacional 2010. Ministerio de Salud, Lima, Peru.
10. Health Communication Partnership. 2004. The role of communication in Peru's fight against tuberculosis. Health Communication Partnership, Baltimore, MD.
11. Asencios L, Quispe N, Mendoza-Ticona A, Leo E, Vásquez L, Jave O, Bonilla CA. 2009. Vigilancia nacional de la resistencia a medicamentos antituberculosos, Peru 2005-2006. Rev Peru Med Exp Salud Publica 26: 278-287.
12. World Health Organization. 2012. Global tuberculosis report 2012. World Health Organization, Geneva, Switzerland.
13. David HL. 1970. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl Microbiol 20: 810-814.
14. Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, Collins D, de Lisle G, Jacobs WR, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230. http://dx.doi.org/10.1126/science.8284673.
15. Garcia de Viedma D, Mokrousov I, Rastogi N. 2011. Innovations in the molecular epidemiology of tuberculosis. Enferm Infecc Microbiol Clin 29(Suppl 1):S8 -S13. http://dx.doi.org/10.1016/S0213-005X(11)70012-X.
16. Kato-Maeda M, Metcalfe JZ, Flores L. 2011. Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies. Future Microbiol 6:203-216. http://dx.doi.org/10.2217/fmb.10.165.
17. Paranjothy S, Eisenhut M, Lilley M, Bracebridge S, Abubakar I, Mulla R, Lack K, Chalkley D, Howard J, Thomas S, McEvoy M. 2008. Extensive transmission of Mycobacterium tuberculosis from 9 year old child with pulmonary tuberculosis and negative sputum smear. BMJ 337:a1184. http://dx.doi.org/10.1136/bmj.a1184.
18. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. 2006. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 19: 658-685. http://dx.doi.org/10.1128/CMR.00061-05.
19. Niemann S, Diel R, Khechinashvili G, Gegia M, Mdivani N, Tang YW. 2010. Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug- resistant tuberculosis in the Republic of Georgia. J Clin Microbiol 48:3544-3550. http://dx.doi.org/10.1128/JCM.00715-10.
20. Comas I, Coscolla M, Luo T, Borrell S, Holt KE, Kato-Maeda M, Parkhill J, Malla B, Berg S, Thwaites G, Yeboah-Manu D, Bothamley G, Mei J, Wei L, Bentley S, Harris SR, Niemann S, Diel R, Aseffa A, Gao Q, Young D, Gagneux S. 2013. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet 45:1176-1182. http://dx.doi.org/10.1038/ng.2744.
21. Wirth T, Hildebrand F, Allix-Beguec C, Wolbeling F, Kubica T, Kremer K, van Soolingen D, Ruïsch-Gerdes S, Locht C, Brisse S, Meyer A, Supply P, Niemann S. 2008. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog 4: e1000160. http://dx.doi.org/10.1371/journal.ppat.1000160.
22. Allix C, Walravens K, Saegerman C, Godfroid J, Supply P, Fauville- Dufaux M. 2006. Evaluation of the epidemiological relevance of variablenumber tandem-repeat genotyping of Mycobacterium bovis and comparison of the method with IS6110 restriction fragment length polymorphism analysis and spoligotyping. J Clin Microbiol 44:1951-1962. http://dx.doi .org/10.1128/JCM.01775-05.
23. Sheen P, Couvin D, Grandjean L, Zimic M, Dominguez M, Luna G, Gilman RH, Rastogi N, Moore DA. 2013. Genetic diversity of Mycobacterium tuberculosis in Peru and exploration of phylogenetic associations with drug resistance. PLoS One 8: e65873. http://dx.doi.org/10.1371/journal.pone.0065873.
24. Caceres O, Rastogi N, Bartra C, Couvin D, Galarza M, Asencios L, Mendoza-Ticona A. 2014. Characterization of the genetic diversity of extensively-drug resistant Mycobacterium tuberculosis clinical isolates from pulmonary tuberculosis patients in Peru. PLoS One 9: e112789. http://dx.doi.org/10.1371/journal.pone.0112789.
25. Taype CA, Agapito JC, Accinelli RA, Espinoza JR, Godreuil S, Goodman SJ, Bañuls AL, Shaw MA. 2012. Genetic diversity, population structure and drug resistance of Mycobacterium tuberculosis in Peru. Infect Genet Evol 12:577-585. http://dx.doi.org/10.1016/j.meegid.2012.02.002.
26. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, Allix C, Aristimuño L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, Cheong S, Diel R, Ellermeier C, Evans JT, Fauville-Dufaux M, Ferdinand S, Garcia de Viedma D, Garzelli C, Gazzola L, Gomes HM, Guttierez MC, Hawkey PM, van Helden PD, Kadival GV, Kreiswirth BN, Kremer K, Kubin M, Kulkarni SP, Liens B, Lillebaek T, Ho ML, Martin C, Martin C, Mokrousov I, Narvskaïa O, Ngeow YF, Naumann L, Niemann S, Parwati I, Rahim Z, Rasolofo-Razanamparany V, Rasolonavalona T, Rossetti ML, Ruïsch-Gerdes S, Sajduda A, Samper S, Shemyakin IG, Singh UB, Somoskovi A, Skuce RA, van Soolingen D, Streicher EM, Suffys PN, Tortoli E, Tracevska T, Vincent V, Victor TC, Warren RM, Yap SF, Zaman K, Portaels F, Rastogi N, Sola C. 2006. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6:23. http://dx.doi.org/10.1186/1471-2180-6-23.
27. Ricaldi JN, Guerra H. 2008. A simple and improved method for diagnosis of tuberculosis using hypertonic saline and sodium hydroxide to concentrate and decontaminate sputum. Trop Doct 38:97-99. http://dx.doi.org/10.1258/td.2007.070024.
28. Sirgel F, Wiid I, van Helden P. 2009. Measuring minimum inhibitory concentrations in mycobacteria. Methods Mol Biol 465:173-186. http://dx.doi.org/10.1007/978-1-59745-207-6-11.
29. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35: 907-914.
30. Supply P. 2005. Multilocus variable number tandem repeat genotyping of Mycobacterium tuberculosis: technical guide. INSERM U629, Institut de Biologie/Institut Pasteur de Lille, Lille, France.
31. Iwamoto T, Grandjean L, Arikawa K, Nakanishi N, Caviedes L, Coronel J, Sheen P, Wada T, Taype CA, Shaw MA, Moore DA, Gilman RH. 2012. Genetic diversity and transmission characteristics of Beijing family strains of Mycobacterium tuberculosis in Peru. PLoS One 7: e49651. http://dx.doi.org/10.1371/journal.pone.0049651.
32. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D. 2006. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 44:4498-4510. http://dx.doi.org/10.1128/JCM.01392-06.
33. Weniger TKJ, Supply P, Niemann S, Harmsen D. 2010. MIRUVNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res 38:W326-W331. http://dx.doi .org/10.1093/nar/gkq351.
34. Shamputa IC, Rigouts L, Eyongeta LA, El Aila NA, van Deun A, Salim AH, Willery E, Locht C, Supply P, Portaels F. 2004. Genotypic and phenotypic heterogeneity among Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients. J Clin Microbiol 42:5528-5536. http://dx.doi.org/10.1128/JCM.42.12.5528-5536.2004.
35. Shamputa IC, Jugheli L, Sadradze N, Willery E, Portaels F, Supply P, Rigouts L. 2006. Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia. Respir Res 7:99. http://dx.doi.org/10.1186/1465-9921-7-99.
36. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, Nicol M, Niemann S, Kremer K, Gutierrez MC, Hilty M, Hopewell PC, Small PM. 2006. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103:2869-2873. http://dx.doi.org/10.1073/pnas.0511240103.
37. Candia N, Lopez B, Zozio T, Carrivale M, Diaz C, Russomando G, de Romero NJ, Jara JC, Barrera L, Rastogi N, Ritacco V. 2007. First insight into Mycobacterium tuberculosis genetic diversity in Paraguay. BMC Microbiol 7:75. http://dx.doi.org/10.1186/1471-2180-7-75.
38. Abadia E, Sequera M, Ortega D, Mendez MV, Escalona A, Da Mata O, Izarra E, Rojas Y, Jaspe R, Motiwala AS, Alland D, de Waard J, Takiff HE. 2009. Mycobacterium tuberculosis ecology in Venezuela: epidemiologic correlates of common spoligotypes and a large clonal cluster defined by MIRU-VNTR-24. BMC Infect Dis 9:122. http://dx.doi.org/10.1186/1471-2334-9-122.
39. Perizzolo PF, Dalla Costa ER, Ribeiro AW, Spies FS, Ribeiro MO, Dias CF, Unis G, Almeida da Silva P, Gomes HM, Suffys PN, Rossetti ML. 2012. Characteristics of multidrug-resistant Mycobacterium tuberculosis in southern Brazil. Tuberculosis 92:56-59. http://dx.doi.org/10.1016/j.tube .2011.09.008.
40. Cerezo I, Jimenez Y, Hernandez J, Zozio T, Murcia MI, Rastogi N. 2012. A first insight on the population structure of Mycobacterium tuberculosis complex as studied by spoligotyping and MIRU-VNTRs in Bogota, Colombia. Infect Genet Evol 12:657-663. http://dx.doi.org/10.1016/j .meegid.2011.07.006.
41. Cohen T, Murray M, Abubakar I, Zhang Z, Sloutsky A, Arteaga F, Chalco K, Franke MF, Becerra MC. 2011. Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru. Emerg Infect Dis 17:969-975. http://dx.doi.org/10.3201/eid1706.101471.
42. Barletta F, Otero L, Collantes J, Asto B, de Jong BC, Seas C, Rigouts L. 2013. Genetic variability of Mycobacterium tuberculosis complex in patients with no known risk factors for MDR-TB in the North-Eastern part of Lima, Peru. BMC Infect Dis 13:397. http://dx.doi.org/10.1186/1471-2334-13-397.
43. Ritacco V, Lopez B, Cafrune PI, Ferrazoli L, Suffys PN, Candia N, Vásquez L, Realpe T, Fernández J, Lima KV, Zurita J, Robledo J, Rossetti ML, Kritski AL, Telles MA, Palomino JC, Heersma H, van Soolingen D, Kremer K, Barrera L. 2008. Mycobacterium tuberculosis strains of the Beijing genotype are rarely observed in tuberculosis patients in South America. Mem Inst Oswaldo Cruz 103:489-492.
44. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK. 1994. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 330:1703-1709. http://dx.doi.org/10.1056/NEJM199406163302402.
45. Barnes PF, Yang Z, Preston-Martin S, Pogoda JM, Jones BE, Otaya M, Eisenach KD, Knowles L, Harvey S, Cave MD. 1997. Patterns of tuberculosis transmission in Central Los Angeles. JAMA 278:1159-1163. http://dx.doi.org/10.1001/jama.1997.03550140051039.
46. Niemann S, Rusch-Gerdes S, Richter E, Thielen H, Heykes-Uden H, Diel R. 2000. Stability of IS6110 restriction fragment length polymorphism patterns of Mycobacterium tuberculosis strains in actual chains of transmission. J Clin Microbiol 38:2563-2567.
47. Comas I, Homolka S, Niemann S, Gagneux S. 2009. Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies. PLoS One 4: e7815. http://dx.doi.org/10.1371/journal.pone.0007815.
48. Affolabi D, Faihun F, Sanoussi N, Anyo G, Shamputa IC, Rigouts L, Kestens L, Anagonou S, Portaels F. 2009. Possible outbreak of streptomycin- resistant Mycobacterium tuberculosis Beijing in Benin. Emerg Infect Dis 15:1123-1125. http://dx.doi.org/10.3201/eid1507.080697.
49. Borgdorff MW, van den Hof S, Kalisvaart N, Kremer K, van Soolingen D. 2011. Influence of sampling on clustering and associations with risk factors in the molecular epidemiology of tuberculosis. Am J Epidemiol 174:243-251. http://dx.doi.org/10.1093/aje/kwr061.
50. Gilks CF, Godfrey-Faussett P, Batchelor BI, Ojoo JC, Ojoo SJ, Brindle RJ, Paul J, Kimari J, Bruce MC, Bwayo J, Plummer FA, Warrell DA. 1997. Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya. AIDS 11:911-918. http://dx.doi.org/10.1097/00002030-199707000-00011.
51. Horsburgh CR, Jr, O'Donnell M, Chamblee S, Moreland JL, Johnson J, Marsh BJ, Narita M, Johnson LS, von Reyn CF. 2010. Revisiting rates of reactivation tuberculosis: a population-based approach. Am J Respir Crit Care Med 182:420-425. http://dx.doi.org/10.1164/rccm.200909-1355OC.
52. World Health Organization. 2011. Global tuberculosis control. WHO/HTM/TB/2011.16. World Health Organization, Geneva, Switzerland.
53. Sutherland I, Svandova E, Radhakrishna S. 1982. The development of clinical tuberculosis following infection with tubercle bacilli. 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of clinical tuberculosis in the Netherlands. Tubercle 63:255-268. http://dx.doi.org/10.1016/S0041-3879(82)80013-5.
54. Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B. 2007. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 21: 1441-1448. http://dx.doi.org/10.1097/QAD.0b013e328216f441.
55. Verver S, Warren RM, Munch Z, Vynnycky E, van Helden PD, Richardson M, van der Spuy GD, Enarson DA, Borgdorff MW, Behr MA, Beyers N. 2004. Transmission of tuberculosis in a high incidence urban community in South Africa. Int J Epidemiol 33:351-357. http://dx.doi.org/10.1093/ije/dyh021.
56. Mulenga C, Shamputa IC, Mwakazanga D, Kapata N, Portaels F, Rigouts L. 2010. Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, Zambia. BMC Infect Dis 10:177. http://dx.doi.org/10.1186/1471-2334-10-177.
57. Tessema B, Beer J, Merker M, Emmrich F, Sack U, Rodloff AC, Niemann S. 2013. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in Northwest Ethiopia: new phylogenetic lineages found in Northwest Ethiopia. BMC Infect Dis 13:131. http://dx.doi .org/10.1186/1471-2334-13-131.
58. Velasquez GE, Yagui M, Cegielski JP, Asencios L, Bayona J, Bonilla C, Jave HO, Yale G, Suárez C, Atwood S, Contreras CC, Shin SS. 2011. Targeted drug-resistance testing strategy for multidrug-resistant tuberculosis detection, Lima, Peru, 2005-2008. Emerg Infect Dis 17:432-440. http://dx.doi.org/10.3201/eid1703.101553.
59. Roetzer A, Diel R, Kohl TA, Ruïckert C, Nuïbel U, Blom J, Wirth T, Jaenicke S, Schuback S, Ruïsch-Gerdes S, Supply P, Kalinowski J, Niemann S. 2013. Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med 10: e1001387. http://dx.doi .org/10.1371/journal.pmed.1001387.
60. Otero L, De Orbegoso A, Navarro AF, Rios J, Parraga T, Gotuzzo E, Seas C, Van der Stuyft P. 2015. Time to initiation of multidrug resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru. Trop Med Int Health 20:322-325. http://dx.doi.org/10.1111/tmi.12430.
61. Glynn JR, Crampin AC, Yates MD, Traore H, Mwaungulu FD, Ngwira BM, Ndlovu R, Drobniewski F, Fine PE. 2005. The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi. J Infect Dis 192:480-487. http://dx.doi.org/10.1086/431517.
62. Instituto Nacional de Estadística e Informática. 2007. Censos nacionales 2007: XI de población y VI de vivienda. Instituto Nacional de Estadística e Informática, Lima, Peru.
63. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. 2002. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol 10:45-52. http://dx.doi.org/10.1016/S0966-842X(01) 02277-6.
64. Devaux I, Kremer K, Heersma H, Van Soolingen D. 2009. Clusters of multidrug-resistant Mycobacterium tuberculosis cases, Europe. Emerg Infect Dis 15:1052-1060. http://dx.doi.org/10.3201/eid1507.080994.
65. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. 2002. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 8:843-849. http://dx.doi.org/10.3201/eid0805.020002.
66. Ministerio de Salud. 2006. Estrategia sanitaria nacional para la prevención y control de la tuberculosis: norma técnica de salud para el control de la tuberculosis. Ministerio de Salud, Lima, Peru.